Conversely, TRAIL neutralization by the injection of either antibodies or soluble TRAIL receptor was shown to enhance the development of EAE [38,44], collagen-induced RA [45], as well as insulitis in non-obese diabetic (NOD) mice [46]. The gene discussed is TNFSF10; the disease is rheumatoid arthritis.